BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 35698239)

  • 1. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
    Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
    J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four distinct ipsilateral vestibular schwannomas: A case of mosaic NF2-related schwannomatosis.
    Tunkel AE; Youner ER; Barseghyan H; Fu Y; Bhattacharya S; Bornhorst M; Monfared AS
    Am J Clin Pathol; 2024 Mar; ():. PubMed ID: 38527168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted massively parallel sequencing of candidate regions on chromosome 22q predisposing to multiple schwannomas: An analysis of 51 individuals in a single-center experience.
    Piotrowski A; Koczkowska M; Poplawski AB; Bartoszewski R; Króliczewski J; Mieczkowska A; Gomes A; Crowley MR; Crossman DK; Chen Y; Lao P; Serra E; Llach MC; Castellanos E; Messiaen LM
    Hum Mutat; 2022 Jan; 43(1):74-84. PubMed ID: 34747535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1: Clinical characteristics and mutation spectrum in a North Indian cohort.
    Srivastava P; Gupta S; Bamba C; Daniel R; Kaur P; Kaur A; Panigrahi I; Mandal K
    Heliyon; 2024 Jan; 10(1):e23685. PubMed ID: 38226287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis.
    Tamura R; Yo M; Toda M
    Neurol Med Chir (Tokyo); 2024 Jun; ():. PubMed ID: 38897938
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Forde C; Smith MJ; Burghel GJ; Bowers N; Roberts N; Lavin T; Halliday J; King AT; Rutherford S; Pathmanaban ON; Lloyd S; Freeman S; Halliday D; Parry A; Axon P; Buttimore J; Afridi S; Obholzer R; Laitt R; Thomas O; Stivaros SM; Vassallo G; Evans DG
    J Med Genet; 2024 Jun; ():. PubMed ID: 38925914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescein-guided removal of peripheral nerve sheath tumors: a preliminary analysis of 20 cases.
    Vetrano IG; Acerbi F; Falco J; Devigili G; Rinaldo S; Messina G; Prada F; D'Ammando A; Nazzi V
    J Neurosurg; 2019 Dec; 134(1):260-269. PubMed ID: 31812148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis.
    Banerjee J; Friedman JM; Klesse LJ; Yohay KH; Jordan JT; Plotkin SR; Allaway RJ; Blakeley JO
    Genet Med; 2023 Feb; 25(2):100324. PubMed ID: 36565307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of
    Reinhold V; Saarinen A; Suominen E; Syrjänen S; Kankuri-Tammilehto M
    Orthop Res Rev; 2023; 15():183-189. PubMed ID: 37791039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Analysis of High Resolution Ultrasound Evaluation of the "Split Fat Sign" in Peripheral Nerve Sheath Tumors.
    Deka JB; Shah R; Jiménez M; Bhatnagar N; Bravo-Sánchez A; Piñas-Bonilla I; Abián-Vicén J; Jiménez F
    Healthcare (Basel); 2023 Dec; 11(24):. PubMed ID: 38132037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.
    Vidal-Millan S; Zatarain-Barrón ZL; Daza-Galicia K; Shveid Gerson D; Pichardo-Rojas PS; Salazar-Pigeon A; Wegman-Ostrosky T
    Front Oncol; 2023; 13():1291286. PubMed ID: 38260834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synchronous Periampullary Tumors in a Patient With Pancreas Divisum and Neurofibromatosis Type 1.
    Gregório C; Rosset C; Alves LDS; Netto CBO; Machado SMDS; Bersch VP; Osvaldt AB; Ashton-Prolla P
    Front Genet; 2020; 11():395. PubMed ID: 32425982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genotype-first approach identifies high incidence of
    Safonov A; Nomakuchi TT; Chao E; Horton C; Dolinsky JS; Yussuf A; Richardson M; Speare V; Li S; Bogus ZC; Bonanni M; Raper A; Kallish S; Ritchie MD; ; ; Nathanson KL; Drivas TG
    medRxiv; 2023 Aug; ():. PubMed ID: 37609227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of infantile spasms with three possibly pathogenic de novo missense variants in NF1 and GABBR1.
    Watanabe K; Kubota K; Nakashima M; Saitsu H
    Hum Genome Var; 2023 Nov; 10(1):30. PubMed ID: 37993422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Pathogenic Missense
    Arshad F; Prasad A; Somaraj A; Udupi GA; Ramakrishnan S; Alladi S
    Dement Neurocogn Disord; 2024 Jan; 23(1):71-73. PubMed ID: 38362057
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Li X; Hu X; Wang P; Cai J
    Front Med (Lausanne); 2024; 11():1346647. PubMed ID: 38576707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and genetic testing outcome of suspected hereditary peripheral nerve sheath tumours in a tertiary cancer institution in Singapore.
    Loh J; Ong PY; Goh DLM; Puhaindran ME; Vellayappan BA; Ow SGW; Chan G; Lee SC
    Hered Cancer Clin Pract; 2022 Jun; 20(1):23. PubMed ID: 35698239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes.
    Perez-Becerril C; Evans DG; Smith MJ
    Hum Mutat; 2021 Oct; 42(10):1187-1207. PubMed ID: 34273915
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.